These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 12030916)

  • 1. The GH-releasing effect of ghrelin, a natural GH secretagogue, is only blunted by the infusion of exogenous somatostatin in humans.
    Di Vito L; Broglio F; Benso A; Gottero C; Prodam F; Papotti M; Muccioli G; Dieguez C; Casanueva FF; Deghenghi R; Ghigo E; Arvat E
    Clin Endocrinol (Oxf); 2002 May; 56(5):643-8. PubMed ID: 12030916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone.
    Arvat E; Maccario M; Di Vito L; Broglio F; Benso A; Gottero C; Papotti M; Muccioli G; Dieguez C; Casanueva FF; Deghenghi R; Camanni F; Ghigo E
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1169-74. PubMed ID: 11238504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of glucose, free fatty acids or arginine load on the GH-releasing activity of ghrelin in humans.
    Broglio F; Benso A; Gottero C; Prodam F; Grottoli S; Tassone F; Maccario M; Casanueva FF; Dieguez C; Deghenghi R; Ghigo E; Arvat E
    Clin Endocrinol (Oxf); 2002 Aug; 57(2):265-71. PubMed ID: 12153607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetylcholine does not play a major role in mediating the endocrine responses to ghrelin, a natural ligand of the GH secretagogue receptor, in humans.
    Broglio F; Gottero C; Benso A; Prodam F; Casanueva FF; Dieguez C; van der Lely AJ; Deghenghi R; Arvat E; Ghigo E
    Clin Endocrinol (Oxf); 2003 Jan; 58(1):92-8. PubMed ID: 12519418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocrine responses to ghrelin in adult patients with isolated childhood-onset growth hormone deficiency.
    Aimaretti G; Baffoni C; Broglio F; Janssen JA; Corneli G; Deghenghi R; van der Lely AJ; Ghigo E; Arvat E
    Clin Endocrinol (Oxf); 2002 Jun; 56(6):765-71. PubMed ID: 12072046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The endocrine response to acute ghrelin administration is blunted in patients with anorexia nervosa, a ghrelin hypersecretory state.
    Broglio F; Gianotti L; Destefanis S; Fassino S; Abbate Daga G; Mondelli V; Lanfranco F; Gottero C; Gauna C; Hofland L; Van der Lely AJ; Ghigo E
    Clin Endocrinol (Oxf); 2004 May; 60(5):592-9. PubMed ID: 15104562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of the growth hormone releasing peptide hexarelin with somatostatin.
    Massoud AF; Hindmarsh PC; Brook CG
    Clin Endocrinol (Oxf); 1997 Nov; 47(5):537-47. PubMed ID: 9425393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of withdrawal of somatostatin plus GH-releasing hormone as a stimulus of GH secretion in obesity.
    Alvarez P; Isidro L; Leal-Cerro A; Casanueva FF; Dieguez C; Cordido F
    Clin Endocrinol (Oxf); 2002 Apr; 56(4):487-92. PubMed ID: 11966741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocrine activities of cortistatin-14 and its interaction with GHRH and ghrelin in humans.
    Broglio F; Arvat E; Benso A; Gottero C; Prodam F; Grottoli S; Papotti M; Muccioli G; van der Lely AJ; Deghenghi R; Ghigo E
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3783-90. PubMed ID: 12161511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortistatin-17 and -14 exert the same endocrine activities as somatostatin in humans.
    Gottero C; Prodam F; Destefanis S; Benso A; Gauna C; Me E; Filtri L; Riganti F; Van Der Lely AJ; Ghigo E; Broglio F
    Growth Horm IGF Res; 2004 Oct; 14(5):382-7. PubMed ID: 15336231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary evidence that Ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans.
    Arvat E; Di Vito L; Broglio F; Papotti M; Muccioli G; Dieguez C; Casanueva FF; Deghenghi R; Camanni F; Ghigo E
    J Endocrinol Invest; 2000 Sep; 23(8):493-5. PubMed ID: 11021763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A low dose of ghrelin stimulates growth hormone (GH) release synergistically with GH-releasing hormone in humans.
    Hataya Y; Akamizu T; Takaya K; Kanamoto N; Ariyasu H; Saijo M; Moriyama K; Shimatsu A; Kojima M; Kangawa K; Nakao K
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4552. PubMed ID: 11549707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased GH secretion and enhanced ACTH and cortisol release after ghrelin administration in Cushing's disease: comparison with GH-releasing peptide-6 (GHRP-6) and GHRH.
    Correa-Silva SR; Nascif SO; Lengyel AM
    Pituitary; 2006; 9(2):101-7. PubMed ID: 16832586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of recombinant human insulin-like growth factor I administration on growth hormone (GH) secretion, both spontaneous and stimulated by GH-releasing hormone or hexarelin, a peptidyl GH secretagogue, in humans.
    Ghigo E; Gianotti L; Arvat E; Ramunni J; Valetto MR; Broglio F; Rolla M; Cavagnini F; Müller EE
    J Clin Endocrinol Metab; 1999 Jan; 84(1):285-90. PubMed ID: 9920097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone (GH)-releasing hormone (GHRH) and the GH secretagogue (GHS), L692,585, differentially modulate rat pituitary GHS receptor and GHRH receptor messenger ribonucleic acid levels.
    Kineman RD; Kamegai J; Frohman LA
    Endocrinology; 1999 Aug; 140(8):3581-6. PubMed ID: 10433214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulational effect of ghrelin on growth hormone secretion from perifused rat anterior pituitary cells.
    Yamazaki M; Nakamura K; Kobayashi H; Matsubara M; Hayashi Y; Kangawa K; Sakai T
    J Neuroendocrinol; 2002 Feb; 14(2):156-62. PubMed ID: 11849375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GH and cortisol rebound rise during and following a somatostatin infusion: studies in dogs with the use of a GH-releasing peptide.
    Rigamonti AE; Bonomo SM; Cella SG; Müller EE
    J Endocrinol; 2002 Sep; 174(3):387-94. PubMed ID: 12208658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans.
    Broglio F; Gottero C; Prodam F; Gauna C; Muccioli G; Papotti M; Abribat T; Van Der Lely AJ; Ghigo E
    J Clin Endocrinol Metab; 2004 Jun; 89(6):3062-5. PubMed ID: 15181099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marked GH secretion after ghrelin alone or combined with GH-releasing hormone (GHRH) in obese patients.
    Alvarez-Castro P; Isidro ML; Garcia-Buela J; Leal-Cerro A; Broglio F; Tassone F; Ghigo E; Dieguez C; Casanueva FF; Cordido F
    Clin Endocrinol (Oxf); 2004 Aug; 61(2):250-5. PubMed ID: 15272922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of withdrawal of somatostatin plus growth hormone (GH)-releasing hormone as a stimulus of GH secretion in Cushing's syndrome.
    Leal-Cerro A; Soto A; Martínez MA; Alvarez P; Isidro L; Casanueva FF; Dieguez C; Cordido F
    Clin Endocrinol (Oxf); 2002 Dec; 57(6):745-9. PubMed ID: 12460324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.